CONOGENETIX BIOSCIENCES
conoGenetix is a privately owned biopharmaceutical company focused on the development of new peptide therapeutics for the treatment of autoimmune diseases. conoGenetix was founded in 2002 by Dr. Andreas Klostermann and Dr. Jörg Stockhaus and is located in Martinsried, Germany. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads that modulate ion channel targets causatively involved in the generation of autoimmune diseases. con... oGenetix runs a program targeting severe autoimmune disorders like Multiple Sclerosis (MS), Rheumatoid Arthritis (RA) and Vasculitis. Several peptides called cgtx-peptides within this program are in preclinical development. The leading indication for the cgtx-peptides will be Vasculitis; a fatal disease strongly related to Rheumatoid Arthritis. Vasculitis is a rare disease and will be a market door opener for conoGenetix.
CONOGENETIX BIOSCIENCES
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2002-01-01
Address:
Martinsried, Bayern, Germany
Country:
Germany
Website Url:
http://www.conogenetix.de
Total Employee:
1+
Status:
Closed
Contact:
+498954726950
Email Addresses:
[email protected]
Total Funding:
1.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome Wordpress Plugins Nginx
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Investors List
BioM AG
BioM AG investment in Series A - ConoGenetix biosciences
Mey Capital Matrix
Mey Capital Matrix investment in Series A - ConoGenetix biosciences
